Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 566

1.

MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.

Ghanem MA, Van der Kwast TH, Sudaryo MK, Mathoera RB, van den Heuvel MM, Al-Doray AA, Nijman RM, van Steenbrugge GJ.

Clin Cancer Res. 2004 Jan 15;10(2):591-7.

PMID:
14760081
[PubMed - indexed for MEDLINE]
Free Article
2.

Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.

Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A, Bovicelli A, Russo G, Giordano GG, McGinnis DE, Giordano A, Cardi G.

Clin Cancer Res. 2002 Jun;8(6):1808-15.

PMID:
12060621
[PubMed - indexed for MEDLINE]
Free Article
3.

Expression and prognostic value of the Ki-67 in Wilms' tumor: experience with 48 cases.

Jurić I, Pogorelić Z, Kuzmić-Prusac I, Biocić M, Jakovljević G, Stepan J, Zupancić B, Culić S, Kruslin B.

Pediatr Surg Int. 2010 May;26(5):487-93. doi: 10.1007/s00383-010-2588-3. Epub 2010 Mar 20.

PMID:
20306058
[PubMed - indexed for MEDLINE]
4.

Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.

Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH.

J Urol. 2000 Dec;164(6):2156-61.

PMID:
11061947
[PubMed - indexed for MEDLINE]
5.

Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.

Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ.

Clin Cancer Res. 2000 Nov;6(11):4265-71.

PMID:
11106242
[PubMed - indexed for MEDLINE]
Free Article
6.

Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.

Sgambato A, Migaldi M, Faraglia B, De Aloysio G, Ferrari P, Ardito R, De Gaetani C, Capelli G, Cittadini A, Trentini GP.

Int J Cancer. 2002 Feb 10;97(5):671-8.

PMID:
11807796
[PubMed - indexed for MEDLINE]
7.

Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.

Migita T, Oda Y, Naito S, Tsuneyoshi M.

Cancer. 2002 Feb 15;94(4):973-9.

PMID:
11920465
[PubMed - indexed for MEDLINE]
Free Article
8.

MIB-1 and p27Kip1 expression in nephroblastoma.

Jones C, Pritchard-Jones K.

Clin Cancer Res. 2004 Nov 15;10(22):7785-6; author reply 7786. No abstract available.

PMID:
15570013
[PubMed - indexed for MEDLINE]
Free Article
9.

Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.

Franke KH, Miklosi M, Goebell P, Clasen S, Steinhoff C, Anastasiadis AG, Gerharz C, Schulz WA.

Urology. 2000 Oct 1;56(4):689-95.

PMID:
11018640
[PubMed - indexed for MEDLINE]
10.

Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.

Kamai T, Takagi K, Asami H, Ito Y, Arai K, Yoshida KI.

BJU Int. 2000 Jul;86(1):14-9.

PMID:
10886076
[PubMed - indexed for MEDLINE]
11.

Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.

Kawauchi S, Goto Y, Liu XP, Furuya T, Oga A, Oda Y, Tsuneyoshi M, Ihara K, Sasaki K.

Cancer. 2001 Mar 1;91(5):1005-12.

PMID:
11251953
[PubMed - indexed for MEDLINE]
12.

The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.

Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Van den Heuvel MM, Noordzij MA, Nijman RJ, Soliman EH, van Steenbrugge GJ.

Br J Cancer. 2001 Nov 16;85(10):1557-63.

PMID:
11720445
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.

Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI.

Br J Cancer. 2001 May 4;84(9):1242-51. Erratum in: Br J Cancer 2001 Aug 3;85(3):471.

PMID:
11336477
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.

Revelos K, Petraki C, Gregorakis A, Scorilas A, Papanastasiou P, Tenta R, Koutsilieris M.

In Vivo. 2005 Sep-Oct;19(5):911-20.

PMID:
16097446
[PubMed - indexed for MEDLINE]
Free Article
15.

P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.

Dybowski B, Kupryjańczyk J, Rembiszewska A, Pykało R, Borkowski A.

Urol Res. 2003 Dec;31(6):397-401. Epub 2003 Sep 27.

PMID:
14517702
[PubMed - indexed for MEDLINE]
16.

Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.

Chae SW, Song JJ, Suh HK, Jung HH, Lim HH, Hwang SJ.

Laryngoscope. 2000 Nov;110(11):1898-901.

PMID:
11081606
[PubMed - indexed for MEDLINE]
17.

Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer.

Vis AN, van Rhijn BW, Noordzij MA, Schröder FH, van der Kwast TH.

J Pathol. 2002 Jun;197(2):148-54.

PMID:
12015737
[PubMed - indexed for MEDLINE]
18.

The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful?

Ghanem MA, van der Kwast TH, Molenaar WM, Safan MA, Nijman RJ, van Steenbrugge GJ.

World J Urol. 2013 Aug;31(4):811-6. doi: 10.1007/s00345-011-0684-1. Epub 2011 May 19.

PMID:
21594709
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.

Noguchi T, Kikuchi R, Ono K, Takeno S, Moriyama H, Uchida Y.

Oncol Rep. 2003 Jul-Aug;10(4):827-31.

PMID:
12792730
[PubMed - indexed for MEDLINE]
20.

Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck.

Choi CS, Choi G, Jung KY, Choi JO, Chae YS.

Head Neck. 2001 Apr;23(4):292-7.

PMID:
11400230
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk